About
Our mission
Governance
Partners
Science
Our Genome Engineering Platform
TALEN® Technology
In-House Manufacturing
Pipeline
Product Candidates
Investors
IR Overview
News
Press releases
Events and Webcasts
Presentations
Corporate presentations
Scientific presentations
Scientific publications
Corporate Governance
Board of Directors
Executive Committee
External Auditors
Governance Documents
General meetings
Financial Information
SEC filings
Financial statements
Voting Rights & Share Capital
Stock information
Shareholders Services
IR Inquiries
IR FAQ
Careers
Our culture
Job opportunities
Contact us
FR
Recherche
›
Press releases
About
Our mission
Governance
Partners
Science
Our Genome Engineering Platform
TALEN® Technology
In-House Manufacturing
Pipeline
Product Candidates
Investors
IR Overview
News
Press releases
Events and Webcasts
Presentations
Corporate presentations
Scientific presentations
Scientific publications
Corporate Governance
Board of Directors
Executive Committee
External Auditors
Governance Documents
General meetings
Financial Information
SEC filings
Financial statements
Voting Rights & Share Capital
Stock information
Shareholders Services
IR Inquiries
IR FAQ
Careers
Our culture
Job opportunities
Contact us
FR
Press releases
All
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
30
Oct 2014
20:30 E.S.T.
Event report: Individual Shareholders’ Meeting held on October 23, 2014
Read more
30
Sep 2014
20:30 E.S.T.
Cellectis: First-half 2014 financial results
Read more
23
Sep 2014
20:30 E.S.T.
Individual Shareholder Meeting
Read more
16
Sep 2014
20:30 E.S.T.
Event report: Cellectis R&D/ Analyst Day
Read more
4
Sep 2014
20:30 E.S.T.
Cellectis announces the closing of the sale of its Swedish subsidiary Cellectis AB to Takara Bio Inc.
Read more
2
Sep 2014
20:30 E.S.T.
Cellectis to Host R&D/ Analyst Day on September 11th at Le Parker Meridien Hotel in New York City
Read more
31
Jul 2014
20:30 E.S.T.
Pfizer’s stake in Cellectis’ capital is welcomed by its Shareholders
Read more
29
Jul 2014
20:30 E.S.T.
Cellectis sells its Swedish subsidiary, Cellectis AB, to the Japanese company Takara Bio Inc.
Read more
30
Jun 2014
20:30 E.S.T.
Cellectis SA Combined General Shareholders’ Meeting of June 27, 2014
Read more
23
Jun 2014
20:30 E.S.T.
Cellectis’ UCART19 receives Advanced-Therapy medicinal Product classification from EMA
Read more
Posts pagination
← PREV
1
…
32
33
34
35
36
…
40
NEXT →
Press contacts
For more information on any story, or for press enquiries, get in touch with our communication team
CONTACT US